Hyperacute Radiation Pneumonitis after Severe irAE

Yang Chou, Wei Kai Chuang

Research output: Contribution to journalArticlepeer-review


A 54-year-old woman presented to an outpatient clinic with a recurrence of triple-negative breast cancer and multiple bone metastases. The patient had a large mass lesion of 10 cm on the sternum. She received the immune checkpoint inhibitors pembrolizumab and taxane. Initially, the patient responded excellently to treatment, but stopped pembrolizumab for grade IV skin toxicity with multiple ulcerative wounds over the bilateral leg and trunk. The lesions abated following administration of antibiotics and oral prednisolone for two months. After that, she was referred to the radiation oncology department for further treatment. She received radiotherapy for the sternum mass but stopped radiation at 42Gy/21 fractions for severe dyspnea and fever. Blood sampling found leukocytosis with neutrophil predominance. Chest radiography showed bilateral lung infiltration. Pulmonary CT scan yielded bilateral lung patchy consolidation compatible with radiation isodose-line. Bronchial lavage showed positive Pneumocystis jiroveci PCR. Dyspnea improved after titrating methylprednisolone within two days. The patient recovered well with TMP-SMX and glucocorticoids after the initiation of therapy.

Original languageEnglish
Article number850
Issue number8
Publication statusPublished - Apr 2024


  • breast cancer
  • immunotherapy
  • radiotherapy

ASJC Scopus subject areas

  • Clinical Biochemistry


Dive into the research topics of 'Hyperacute Radiation Pneumonitis after Severe irAE'. Together they form a unique fingerprint.

Cite this